Algernon Pharmaceuticals Statistics

Total Valuation

CSE:AGN has a market cap or net worth of CAD 2.46 million. The enterprise value is 2.10 million.

Market Cap	2.46M
Enterprise Value	2.10M

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:AGN has 27.30 million shares outstanding. The number of shares has increased by 37.20% in one year.

Current Share Class	n/a
Shares Outstanding	27.30M
Shares Change (YoY)	+37.20%
Shares Change (QoQ)	+16.73%
Owned by Insiders (%)	14.84%
Owned by Institutions (%)	16.67%
Float	23.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.37
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.79
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.23

Current Ratio	0.23
Quick Ratio	0.20
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -25.89% and return on invested capital (ROIC) is -96.20%.

Return on Equity (ROE)	-25.89%
Return on Assets (ROA)	-35.42%
Return on Invested Capital (ROIC)	-96.20%
Return on Capital Employed (ROCE)	-120.55%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.17% in the last 52 weeks. The beta is -0.07, so CSE:AGN's price volatility has been lower than the market average.

Beta (5Y)	-0.07
52-Week Price Change	-29.17%
50-Day Moving Average	0.09
200-Day Moving Average	0.10
Relative Strength Index (RSI)	47.10
Average Volume (20 Days)	26,289

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.16M
Pretax Income	-362,491
Net Income	-362,491
EBITDA	-2.13M
EBIT	-2.16M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 357,923 in cash and n/a in debt, giving a net cash position of 357,923 or 0.01 per share.

Cash & Cash Equivalents	357,923
Total Debt	n/a
Net Cash	357,923
Net Cash Per Share	0.01
Equity (Book Value)	1.79M
Book Value Per Share	0.07
Working Capital	-1.44M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.90M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:AGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.20%
Shareholder Yield	-37.20%
Earnings Yield	-14.75%
FCF Yield	n/a

Stock Splits

The last stock split was on March 3, 2023. It was a forward split with a ratio of 4.

Last Split Date	Mar 3, 2023
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a